DIMENSIONAL FUND ADVISORS LP - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$3,683,000
+339.0%
629,658
-2.4%
0.00%
Q4 2018$839,000
-63.3%
645,008
-2.6%
0.00%
-100.0%
Q3 2018$2,284,000
+12.3%
661,961
+48.1%
0.00%0.0%
Q2 2018$2,034,000
+220.3%
447,026
+132.4%
0.00%
Q1 2018$635,000
+370.4%
192,330
+456.7%
0.00%
Q4 2017$135,000
-31.1%
34,546
+82.8%
0.00%
Q3 2017$196,000
+6.5%
18,8960.0%0.00%
Q2 2017$184,000
+55.9%
18,896
+9.3%
0.00%
Q1 2017$118,00017,2960.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2019
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders